These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9316852)

  • 41. Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys.
    Xin T; Ai Y; Gerhardt G; Gash D; Zhang Z
    Biochem Biophys Res Commun; 2008 Jun; 370(3):434-9. PubMed ID: 18381061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys.
    Ohshima-Hosoyama S; Simmons HA; Goecks N; Joers V; Swanson CR; Bondarenko V; Velotta R; Brunner K; Wood LD; Hruban RH; Emborg ME
    PLoS One; 2012; 7(6):e39036. PubMed ID: 22745701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease.
    Lapchak PA; Miller PJ; Jiao S; Araujo DM; Hilt D; Collins F
    Neurodegeneration; 1996 Sep; 5(3):197-205. PubMed ID: 8910897
    [No Abstract]   [Full Text] [Related]  

  • 44. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys.
    Hovland DN; Boyd RB; Butt MT; Engelhardt JA; Moxness MS; Ma MH; Emery MG; Ernst NB; Reed RP; Zeller JR; Gash DM; Masterman DM; Potter BM; Cosenza ME; Lightfoot RM
    Toxicol Pathol; 2007 Aug; 35(5):676-92. PubMed ID: 17763282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity.
    Luz M; Allen PC; Bringas J; Boiko C; Stockinger DE; Nikula KJ; Lewis O; Woolley M; Fibiger HC; Bankiewicz K; Mohr E
    Arch Toxicol; 2018 Jul; 92(7):2353-2367. PubMed ID: 29785638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GDNF-induced cerebellar toxicity: A brief review.
    Luz M; Mohr E; Fibiger HC
    Neurotoxicology; 2016 Jan; 52():46-56. PubMed ID: 26535469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS.
    Lapchak PA
    Rev Neurosci; 1996; 7(3):165-76. PubMed ID: 8916290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New treatment improves symptoms of Parkinson's disease.
    Mayor S
    BMJ; 2002 Apr; 324(7344):997. PubMed ID: 11976237
    [No Abstract]   [Full Text] [Related]  

  • 49. Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys.
    Grondin R; Cass WA; Zhang Z; Stanford JA; Gash DM; Gerhardt GA
    J Neurosci; 2003 Mar; 23(5):1974-80. PubMed ID: 12629203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal.
    Slevin JT; Gash DM; Smith CD; Gerhardt GA; Kryscio R; Chebrolu H; Walton A; Wagner R; Young AB
    J Neurosurg; 2007 Apr; 106(4):614-20. PubMed ID: 17432712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glial cell line-derived neurotrophic factor protects against ischemia/hypoxia-induced brain injury in neonatal rat.
    Ikeda T; Xia XY; Xia YX; Ikenoue T; Han B; Choi BH
    Acta Neuropathol; 2000 Aug; 100(2):161-7. PubMed ID: 10963363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuron saving schemes.
    Lindsay RM
    Nature; 1995 Jan; 373(6512):289-90. PubMed ID: 7830762
    [No Abstract]   [Full Text] [Related]  

  • 53. Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.
    Emborg ME; Moirano J; Raschke J; Bondarenko V; Zufferey R; Peng S; Ebert AD; Joers V; Roitberg B; Holden JE; Koprich J; Lipton J; Kordower JH; Aebischer P
    Neurobiol Dis; 2009 Nov; 36(2):303-11. PubMed ID: 19660547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GDNF delivery for Parkinson's disease.
    Patel NK; Gill SS
    Acta Neurochir Suppl; 2007; 97(Pt 2):135-54. PubMed ID: 17691299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GDNF treatment in Parkinson's disease: time for controlled clinical trials?
    Brundin P
    Brain; 2002 Oct; 125(Pt 10):2149-51. PubMed ID: 12244075
    [No Abstract]   [Full Text] [Related]  

  • 56. Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease.
    Yasuhara T; Shingo T; Date I
    Acta Med Okayama; 2007 Apr; 61(2):51-6. PubMed ID: 17471304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety Assessment of AAV2-hGDNF Administered Via Intracerebral Injection in Rats for Treatment of Parkinson's Disease.
    Terse PS; Kells AP; Noker P; Wright JF; Bankiewicz KS
    Int J Toxicol; 2021; 40(1):4-14. PubMed ID: 33131343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ameliorative effect of glial cell line-derived neurotrophic factor on brain edema formation after permanent middle cerebral artery occlusion in rats.
    Kitagawa H; Abe K; Hayashi T; Mitsumoto Y; Koga N; Itoyama Y
    Neurol Res; 1998 Jun; 20(4):333-6. PubMed ID: 9618697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys.
    Luan L; Ding F; Ai Y; Andersen A; Hardy P; Forman E; Gerhardt GA; Gash DM; Grondin R; Zhang Z
    Cell Transplant; 2008; 17(4):417-25. PubMed ID: 18522244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys.
    Hovland DN; Boyd RB; Butt MT; Engelhardt JA; Moxness MS; Ma MH; Emery MG; Ernst NB; Reed RP; Zeller JR; Gash DM; Masterman DM; Potter BM; Cosenza ME; Lightfoot RM
    Toxicol Pathol; 2007 Dec; 35(7):1013-29. PubMed ID: 18098052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.